Annual Shareholders Equity
$462.00 M
-$195.00 M-29.68%
31 December 2023
Summary:
Arcus Biosciences annual stockholders equity is currently $462.00 million, with the most recent change of -$195.00 million (-29.68%) on 31 December 2023. During the last 3 years, it has fallen by -$40.30 million (-8.02%). RCUS annual shareholders equity is now -45.13% below its all-time high of $842.00 million, reached on 31 December 2021.RCUS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$565.00 M
-$70.00 M-11.02%
30 September 2024
Summary:
Arcus Biosciences quarterly stockholders equity is currently $565.00 million, with the most recent change of -$70.00 million (-11.02%) on 30 September 2024. Over the past year, it has increased by +$45.00 million (+8.65%). RCUS quarterly shareholders equity is now -32.90% below its all-time high of $842.00 million, reached on 31 December 2021.RCUS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -29.7% | +8.7% |
3 y3 years | -8.0% | +4.1% |
5 y5 years | +96.6% | +218.8% |
RCUS Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -45.1% | at low | -32.9% | +22.3% |
5 y | 5 years | -45.1% | +182.0% | -32.9% | +301.7% |
alltime | all time | -45.1% | +364.5% | -32.9% | +301.7% |
Arcus Biosciences Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $565.00 M(-11.0%) |
June 2024 | - | $635.00 M(-10.2%) |
Mar 2024 | - | $707.00 M(+53.0%) |
Dec 2023 | $462.00 M(-29.7%) | $462.00 M(-11.2%) |
Sept 2023 | - | $520.00 M(-8.1%) |
June 2023 | - | $566.00 M(-5.7%) |
Mar 2023 | - | $600.00 M(-8.7%) |
Dec 2022 | $657.00 M(-22.0%) | $657.00 M(-6.0%) |
Sept 2022 | - | $698.70 M(-6.5%) |
June 2022 | - | $747.39 M(-6.2%) |
Mar 2022 | - | $796.58 M(-5.4%) |
Dec 2021 | $842.00 M | $842.00 M(+55.2%) |
Sept 2021 | - | $542.61 M(-10.2%) |
June 2021 | - | $604.55 M(-9.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $664.79 M(+32.3%) |
Dec 2020 | $502.30 M(+206.6%) | $502.30 M(-7.7%) |
Sept 2020 | - | $544.42 M(+27.0%) |
June 2020 | - | $428.71 M(+204.8%) |
Mar 2020 | - | $140.64 M(-14.2%) |
Dec 2019 | $163.84 M(-30.3%) | $163.84 M(-7.6%) |
Sept 2019 | - | $177.23 M(-9.9%) |
June 2019 | - | $196.65 M(-11.2%) |
Mar 2019 | - | $221.57 M(-5.7%) |
Dec 2018 | $234.94 M(+52.7%) | $234.94 M(-4.2%) |
Sept 2018 | - | $245.12 M(-3.7%) |
June 2018 | - | $254.57 M(-4.5%) |
Mar 2018 | - | $266.59 M(+73.3%) |
Dec 2017 | $153.87 M(+54.7%) | $153.87 M |
Dec 2016 | $99.46 M | - |
FAQ
- What is Arcus Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Arcus Biosciences?
- What is Arcus Biosciences annual shareholders equity year-on-year change?
- What is Arcus Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Arcus Biosciences?
- What is Arcus Biosciences quarterly shareholders equity year-on-year change?
What is Arcus Biosciences annual stockholders equity?
The current annual shareholders equity of RCUS is $462.00 M
What is the all time high annual shareholders equity for Arcus Biosciences?
Arcus Biosciences all-time high annual stockholders equity is $842.00 M
What is Arcus Biosciences annual shareholders equity year-on-year change?
Over the past year, RCUS annual stockholders equity has changed by -$195.00 M (-29.68%)
What is Arcus Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of RCUS is $565.00 M
What is the all time high quarterly shareholders equity for Arcus Biosciences?
Arcus Biosciences all-time high quarterly stockholders equity is $842.00 M
What is Arcus Biosciences quarterly shareholders equity year-on-year change?
Over the past year, RCUS quarterly stockholders equity has changed by +$45.00 M (+8.65%)